November 17th, 2013
Remaking the Heart: Stem Cells, Patches, Scaffolds, and More
Vimal Ramjee, MD
Which advance in regenerative cardiovascular biology has the best chance of being translated into a clinical treatment? A cardiology Fellow ponders cutting-edge science presentations at AHA.13.
NEJM Journal Watch — Recent Cardiology Articles- Atrial Fibrillation and Stable Coronary Artery Disease — What Is the Optimal Anticoagulation–Antiplatelet Regimen?
- β-Blockers After Myocardial Infarction
- Updated Guideline for Perioperative Cardiovascular Management of Patients Undergoing Noncardiac Surgery
- Strategies and Criteria for the Diagnosis and Management of Myocarditis
- Sex-Based Disparity in CABG Outcomes: Are We Moving Toward Parity?